ENTITY
Shinpoong Pharmaceutical

Shinpoong Pharmaceutical (019170 KS)

79
Analysis
Health Care • South Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
•15 Jun 2020 12:13

SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)

In this insight, we provide a valuation analysis of SK Biopharmaceuticals (BIO SK).Bullish Case Valuation - If we take a bullish case valuation...

Logo
537 Views
Share
•21 Sep 2017 19:58

TissueGene IPO Part 1 - IPO Prospectus Summary

What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...

Logo
871 Views
Share
x